It is well established that direct oral anticoagulants (DOACs) are the cornerstone of
anticoagulant strategy in atrial fibrillation (AF) and venous thromboembolism (VTE) and …

Background Despite numerous randomized clinical trials (RCT), data regarding the efficacy
of antiplatelet and anticoagulant combinations are still conflicting. We aimed to analyze …

Background: While current clinically administered anticoagulant medications have
demonstrated effectiveness, they have also precipitated significant risks: severe bleeding …

Exosomes are participated in the pathogenesis of cardiovascular diseases and can be
secreted by mesenchymal stem cells (MSCs). However, the effects of circRNA, delivered by …

Introduction Atrial fibrillation (AF) cannot be considered an isolated disease. Patients with AF
should be managed using a comprehensive approach that is not limited to stroke …

Introduction In addition to an increased risk of thromboembolic complications, patients with
atrial fibrillation (AF) are at risk for vascular events. Consequently, complete vascular …

Acute coronary syndrome (ACS) is a leading cause of mortality worldwide. Despite optimal
antiplatelet therapy recommendation after ischemic events, recurrent thrombotic …

The study aimed to assess the risk of myocardial infarction (MI) and major adverse cardiac
events during non-vitamin K antagonist oral anticoagulants (NOAC) compared to warfarin …

A small natural substance called cirsilineol (CSL), which was discovered in the plant
Artemisia vestita, is lethal to many cancer cells and has antioxidant, anticancer, and …

Discovery and selection of the potential targets are some of the important issues in
pharmacology. Even when all the reactions and the proteins in a biological network are …